Dr. Lippincott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Brady 522B
Baltimore, MD 21287Phone+1 410-583-2900Fax+1 410-583-2654
Education & Training
- University of North Carolina HospitalsFellowship, Infectious Disease, 2010 - 2013
- Ohio State University HospitalResidency, Internal Medicine, 2006 - 2009
- University of Virginia School of MedicineClass of 2006
Certifications & Licensure
- MD State Medical License 2015 - 2026
- NC State Medical License 2010 - 2016
- OH State Medical License 2006 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 3 citationsEfficacy of epetraborole againstin a mouse model of lung infection.Binayak Rimal, Christopher K Lippincott, Chandra M Panthi, Yi Xie, Tiffany R Keepers
Antimicrobial Agents and Chemotherapy. 2024-08-07 - 1 citationsEfficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model oflung disease.Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott
Msphere. 2024-07-30 - 1 citationsCase Commentary: Dual β-lactam as part of regimen to treatlung disease.Christopher K Lippincott, Gyanu Lamichhane
Antimicrobial Agents and Chemotherapy. 2024-07-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: